Unveiling 5 Analyst Insights On Aflac
Portfolio Pulse from Benzinga Insights
Aflac (NYSE:AFL) has received mixed analyst ratings over the past three months, with a recent shift towards more positive evaluations. The average 12-month price target for Aflac has been raised to $81.00, up from $75.00, indicating an 8.0% increase. Analysts from firms like Raymond James, UBS, Goldman Sachs, Evercore ISI Group, and Morgan Stanley have adjusted their ratings and price targets, reflecting a nuanced view of Aflac's market position and financial performance. Aflac's financial indicators, such as market capitalization, revenue growth, net margin, ROE, ROA, and debt management, underscore its robust market position and financial health.
February 02, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Aflac has seen a positive shift in analyst ratings with an increased average price target of $81.00, reflecting optimism about its financial health and market position.
The increase in Aflac's average price target by analysts, along with positive adjustments in ratings, suggests growing confidence in the company's financial performance and market position. Given Aflac's solid revenue growth, impressive net margin, and strong ROE and ROA, the positive analyst sentiment is likely to contribute to a favorable short-term impact on Aflac's stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100